Objective:

To outline key metrics used by sponsors and CROs for evaluating and selecting clinical research sites in ophthalmology, emphasizing the strategic importance of this selection for clinical trial success.

Key Findings:

• Access to the right patient population is critical for site selection, particularly in urban versus rural settings.
• Past recruitment performance is a strong predictor of future success, especially when contextualized with resources used.
• Retention of patients throughout the study is essential for data integrity, often linked to strong clinical communication.
• Operational reliability is influenced by the experience of investigators and coordinators, which can be demonstrated through past performance.

Interpretation:

Effective site selection and management are crucial for timely and successful clinical trials, directly impacting the approval and availability of new therapies, which ultimately benefits patient access.

Limitations:

• The article does not provide specific quantitative metrics for site evaluation, which could limit practical application.
• It lacks detailed case studies or examples of successful site partnerships, which could enhance understanding of best practices.

Conclusion:

Understanding and aligning with sponsor expectations can position sites as valuable partners in clinical research, ultimately benefiting patient access to innovative therapies and enhancing the likelihood of trial success.